Synergy CHC Corp. has developed two marquee nutraceutical brands—FOCUSfactor, a clinically validated brain health supplement, and Flat Tummy, focused on women's nutrition—that have driven SKU proliferation and geographic expansion. Despite these product portfolio advances and an asset-light manufacturing model enabling scalability, the company faces declining revenues and mounting losses, including a 12.8% revenue drop alongside an operating loss of $8.5 million in 2025 [F1]. Intensifying regulatory scrutiny and legal risks inherent to the fragmented U.S. supplement market burden operations. Moreover, Synergy’s significant financial leverage and negative equity strain its capital flexibility, raising questions about near-term growth funding and debt servicing [S9][S21].